CytoDyn Inc.
CYDY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001175680
No open-market purchases or sales by CytoDyn Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $35.2K in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in CytoDyn Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −1 vs. Q1 2021
- Shares held
- 837.9K
- +55.5K (+7.1%) vs. Q1 2021
- Total value
- $1.43M
- −$681.0K (−32.2%) vs. Q1 2021
- New holders
- 5
- 3 more added
- Sold out
- 6
- 5 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CYDY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $35.2K |
| Q1 2026 | 9 | $87.1K |
| Q4 2025 | 8 | $91.0K |
| Q3 2025 | 11 | $120.5K |
| Q2 2025 | 11 | $76.4K |
| Q1 2025 | 11 | $64.7K |
| Q4 2024 | 10 | $29.8K |
| Q3 2024 | 9 | $64.6K |
| Q2 2024 | 11 | $37.4K |
| Q1 2024 | 12 | $47.9K |
| Q4 2023 | 11 | $92.5K |
| Q3 2023 | 9 | $41.2K |
| Q2 2023 | 12 | $146.5K |
| Q1 2023 | 11 | $162.5K |
| Q4 2022 | 12 | $110.8K |
| Q3 2022 | 13 | $315.0K |
| Q2 2022 | 13 | $208.3K |
| Q1 2022 | 16 | $191.5K |
| Q4 2021 | 18 | $568.8K |
| Q3 2021 | 16 | $1.21M |
| Q2 2021 | 20 | $1.43M |
| Q1 2021 | 21 | $2.11M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding CytoDyn Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Firsthand Capital Management, Inc. | 222,730 | $379.0K | 0.10% | −100,000−31.0% | Reduced |
| Fairfield, Bush & Co. | 155,109 | $264.0K | 0.07% | +29,200+23.2% | Added |
| Capital Advantage, Inc. | 91,000 | $155.0K | 0.04% | +91,000 | New |
| Willis Investment Counsel | 87,237 | $148.0K | 0.01% | +87,237 | New |
| L & S Advisors Inc | 50,600 | $86.0K | 0.01% | 00.0% | Unchanged |
| Diversified Trust Co | 45,790 | $78.0K | 0.00% | 00.0% | Unchanged |
| Hollencrest Capital Management | 38,500 | $65.0K | 0.01% | −1,000−2.5% | Reduced |
| Moloney Securities Asset Management, LLC | 28,275 | $48.0K | 0.01% | −7,000−19.8% | Reduced |
| MAI Capital Management | 25,000 | $43.0K | 0.00% | +25,000 | New |
| Captrust Financial Advisors | 24,875 | $42.0K | 0.00% | +8,738+54.1% | Added |
| S.A. Mason LLC | 19,000 | $32.0K | 0.02% | 00.0% | Unchanged |
| Inverness Counsel LLC | 10,000 | $17.0K | 0.00% | 00.0% | Unchanged |
| FineMark National Bank & Trust | 10,000 | $17.0K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 9,274 | $17.0K | 0.00% | +1,708+22.6% | Added |
| Ancora Advisors, LLC | 9,488 | $16.0K | 0.00% | −120−1.2% | Reduced |
| McCarthy Asset Management, Inc. | 4,300 | $7.00K | 0.00% | −825−16.1% | Reduced |
| Caz Investments LP | 4,000 | $7.00K | 0.01% | 00.0% | Unchanged |
| Holloway Wealth Management, LLC | – | $6.00K | 0.00% | – | New |
| Tradition Wealth Management, LLC | 2,697 | $5.00K | 0.00% | +2,697 | New |
| Dividend Assets Capital, LLC | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Next Capital Management LLC | 0 | $0 | 0.00% | −37,500−100.0% | Sold out |
| Livingston Group Asset Management CO (operating as Southport Capital Management) | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| Auxier Asset Management | 0 | $0 | 0.00% | −14,300−100.0% | Sold out |
| Taylor Wealth Management Partners | 0 | $0 | 0.00% | −11,950−100.0% | Sold out |
| Crescent Capital Consulting, LLC | 0 | $0 | 0.00% | −225−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |